Article
[Myoblast transplantation for heart failure: where are we heading?].
Archives des maladies du coeur et des vaisseaux - 1 Jun 2005
Menasché P, Hagège A A, Desnos M
Abstract excerpt
Cell therapy in cardiology is already a reality, as evidenced by the number of ongoing clinical trials. These studies entail administration of either skeletal myoblasts in patients with severe ischemic left ventricular dysfunction or of bone marrow-derived cells in patients with acute myocardial infarction and in whom cell therapy is an adjunct to a percutaneous revascularization procedure. The techniques of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
